Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

ImaginAb (Inglewood, CA) a clinical-stage biopharmaceutical company focused on re-engineered therapeutic antibody fragments against biologic targets for diagnostic imaging with Positron Emission Tomography scans for management of cancer and autoimmune disease, closed a $12.5M Series B financing. Participants include Novartis Venture Funds, Merieux Developpement, Nextech Invest, Cycad Group and Momentum Biosciences.

Circle Cardiovascular Imaging (Canada) a commercial-stage analytical software company focused on cardiac imaging, closed a $3.9M Series B financing. Participants include Business Development Bank of Canada, Foundation Equity and First Yellowhead Equities. Thanx for your patience as we catch-up.

DICOM Grid (Phoenix, AZ) a development-stage bioinformatics company focused on the development of medical imaging software, closed a $7.5M Series A financing. Participants include Canaan Partners and CHL Medical Partners.

Marval Biosciences (San Diego, CA) a preclinical-stage biopharma company focused on the reformulation of contrast dyes for CT scans using liposomal nanoparticles, closed a $2.5M Series B financing. Participants include DFJ Frontier and DFJ Mercury. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Avid Radiopharmaceuticals (Philadelphia, PA) a development-stage company focused on molecular imaging compounds for diagnostic and detection use in Alzheimer’s, dementia, Parkinson’s and diabetes, closed a $24.5M Series D financing. Participants include Alta Partners, AllianceBernstein, Safeguard Scientifics, Pfizer Venture Investments, Lilly Ventures, RK Ventures Group and BioAdvance.

Rcadia Medical Imaging (Israel) developer of image processing based software products for blood vessel analysis closed a $3.3M Series B financing. Participants include BioVentures Investors and 20/20 HealthCare Partners.

Orthoscan (Scottsdale, AZ) developer of medical device imaging products with a focus on orthopaedics, closed a $7.5M Series B financing. Participants include River Cities Capital Funds, Aphelion Capital and California Technology Ventures.

BioImagene (Cupertino, CA) commercial-stage provider of digital pathology solutions for cancer diagnosis and preclinical research, closed a $26M Series D financing. Participants include Burrill & Co., Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures.

Celleration (Eden Prairie, MN) commercial-stage medical device company focused on non-contact ultrasound device for wound care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

HyperMed (Burlington, MA) early-stage company focused on hyperspectral medical imaging, closed a $4M Series B financing. Participants include GBP Capital.

VisEn Medical (Woburn, MA) commercial-stage company focused on fluorescence in vivo imaging, closed a $5M Series B financing. Participants include Merck Capital Ventures and Flagship Ventures.

Micrima (England) early-stage stage company focused on the radio wave technology to improve detection of breast cancer, closed a $3.5M Series A financing. Participants include YFM Group, Swarraton Partners and Nesta.

  

to top of page...